NCT06855524View on ClinicalTrials.gov

Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 6, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Malignant Digestive System NeoplasmMalignant Female Reproductive System Neoplasm
Interventions
PROCEDURE

Biospecimen Collection

Undergo blood sample collection

DIETARY_SUPPLEMENT

Oligo-fucoidan

Given PO

DRUG

Placebo Administration

Given PO

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

85259

RECRUITING

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06855524 - Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer | Biotech Hunter | Biotech Hunter